199 related articles for article (PubMed ID: 36110429)
1. Alzheimer's Disease Polygenic Risk Score Is Not Associated With Cognitive Decline Among Older Adults With Type 2 Diabetes.
Manzali SB; Yu E; Ravona-Springer R; Livny A; Golan S; Ouyang Y; Lesman-Segev O; Liu L; Ganmore I; Alkelai A; Gan-Or Z; Lin HM; Heymann A; Schnaider Beeri M; Greenbaum L
Front Aging Neurosci; 2022; 14():853695. PubMed ID: 36110429
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score.
Tomassen J; den Braber A; van der Lee SJ; Reus LM; Konijnenberg E; Carter SF; Yaqub M; van Berckel BNM; Collij LE; Boomsma DI; de Geus EJC; Scheltens P; Herholz K; Tijms BM; Visser PJ
BMC Neurol; 2022 Dec; 22(1):484. PubMed ID: 36522743
[TBL] [Abstract][Full Text] [Related]
3. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
[TBL] [Abstract][Full Text] [Related]
4. A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease.
Porter T; Burnham SC; Savage G; Lim YY; Maruff P; Milicic L; Peretti M; Ames D; Masters CL; Martins RN; Rainey-Smith S; Rowe CC; Salvado O; Taddei K; Groth D; Verdile G; Villemagne VL; Laws SM
Front Aging Neurosci; 2018; 10():423. PubMed ID: 30620773
[TBL] [Abstract][Full Text] [Related]
5. Association of the CD2AP locus with cognitive functioning among middle-aged individuals with a family history of Alzheimer's disease.
Manzali SB; Ravona-Springer R; Alkelai A; Yu E; Gan-Or Z; Ganmore I; Heymann A; Beeri MS; Greenbaum L
Neurobiol Aging; 2021 May; 101():50-56. PubMed ID: 33578194
[TBL] [Abstract][Full Text] [Related]
6. Physical Activity Is Associated with Slower Cognitive Decline in Older Adults with Type 2 Diabetes.
Rabinowitz Y; Ravona-Springer R; Heymann A; Moshier E; Berman Y; Schwartz J; Sano M; Aisenberg D; Schnaider-Beeri M
J Prev Alzheimers Dis; 2023; 10(3):497-502. PubMed ID: 37357290
[TBL] [Abstract][Full Text] [Related]
7. Deterioration in Motor Function Over Time in Older Adults With Type 2 Diabetes is Associated with Accelerated Cognitive Decline.
Ganmore I; Elkayam I; Ravona-Springer R; Lin HM; Liu X; Plotnik M; Buchman AS; Berman Y; Schwartz J; Sano M; Heymann A; Beeri MS
Endocr Pract; 2020 Oct; 26(10):1143-1152. PubMed ID: 33471716
[TBL] [Abstract][Full Text] [Related]
8. Polygenic coronary artery disease association with brain atrophy in the cognitively impaired.
de Silva E; Sudre CH; Barnes J; Scelsi MA; Altmann A;
Brain Commun; 2022; 4(6):fcac314. PubMed ID: 36523268
[TBL] [Abstract][Full Text] [Related]
9. Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older population.
Riaz M; Huq A; Ryan J; Orchard SG; Tiller J; Lockery J; Woods RL; Wolfe R; Renton AE; Goate AM; Sebra R; Schadt E; Brodtmann A; Shah RC; Storey E; Murray AM; McNeil JJ; Lacaze P
Aging Cell; 2021 Jun; 20(6):e13384. PubMed ID: 34041846
[TBL] [Abstract][Full Text] [Related]
10. Poor self-rated health is associated with faster cognitive decline and greater small vessel disease in older adults with type 2 diabetes.
Ramsingh N; Lin HM; Ouyang Y; Ravona-Springer R; Livny A; Soleimani L; Bendlin BB; Meir MB; Heymann A; Sano M; Azuri J; Beeri MS
Diabetes Metab Res Rev; 2024 Jan; 40(1):e3761. PubMed ID: 38287720
[TBL] [Abstract][Full Text] [Related]
11. The Molecular and Neuropathological Consequences of Genetic Risk for Alzheimer's Dementia.
Tasaki S; Gaiteri C; Mostafavi S; De Jager PL; Bennett DA
Front Neurosci; 2018; 12():699. PubMed ID: 30349450
[TBL] [Abstract][Full Text] [Related]
12. Increase in Number of Depression Symptoms Over Time is Related to Worse Cognitive Outcomes in Older Adults With Type 2 Diabetes.
Ravona-Springer R; Heymann A; Lin HM; Liu X; Berman Y; Schwartz J; Soleimani L; Sano M; Beeri MS
Am J Geriatr Psychiatry; 2021 Jan; 29(1):1-11. PubMed ID: 33127316
[TBL] [Abstract][Full Text] [Related]
13. Age Modulates the Association of Caffeine Intake With Cognition and With Gray Matter in Elderly Diabetics.
West RK; Ravona-Springer R; Livny A; Heymann A; Shahar D; Leroith D; Preiss R; Zukran R; Silverman JM; Schnaider-Beeri M
J Gerontol A Biol Sci Med Sci; 2019 Apr; 74(5):683-688. PubMed ID: 29982422
[TBL] [Abstract][Full Text] [Related]
14. Effect of Pathway-specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-related Biomarkers among Asymptomatic Individuals.
Xu Y; Vasiljevic E; Deming YK; Jonaitis EM; Koscik RL; Van Hulle CA; Lu Q; Carboni M; Kollmorgen G; Wild N; Carlsson CM; Johnson SC; Zetterberg H; Blennow K; Engelman CD
medRxiv; 2023 Feb; ():. PubMed ID: 36778431
[TBL] [Abstract][Full Text] [Related]
15. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
16. Baseline cognition is the best predictor of 4-year cognitive change in cognitively intact older adults.
Schaeverbeke JM; Gabel S; Meersmans K; Luckett ES; De Meyer S; Adamczuk K; Nelissen N; Goovaerts V; Radwan A; Sunaert S; Dupont P; Van Laere K; Vandenberghe R
Alzheimers Res Ther; 2021 Apr; 13(1):75. PubMed ID: 33827690
[TBL] [Abstract][Full Text] [Related]
17. Effects of polygenic risk for Alzheimer's disease on rate of cognitive decline in normal aging.
Kauppi K; Rönnlund M; Nordin Adolfsson A; Pudas S; Adolfsson R
Transl Psychiatry; 2020 Jul; 10(1):250. PubMed ID: 32709845
[TBL] [Abstract][Full Text] [Related]
18. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
19. Polygenic resilience score may be sensitive to preclinical Alzheimer's disease changes.
Eissman JM; Wells G; Khan OA; Liu D; Petyuk VA; Gifford KA; Dumitrescu L; Jefferson AL; Hohman TJ
Pac Symp Biocomput; 2023; 28():449-460. PubMed ID: 36540999
[TBL] [Abstract][Full Text] [Related]
20. Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis.
Baker JE; Lim YY; Pietrzak RH; Hassenstab J; Snyder PJ; Masters CL; Maruff P
Alzheimers Dement (Amst); 2017; 6():108-121. PubMed ID: 28239636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
